8
Shared Docs
8
Same-Page
20 / 8
Mentions
From: To: Subject: Date: Attachments: Jeffrey Epstein <[email protected]> Fwd: Introducing
From: To: Subject: Date: Attachments: Jeffrey Epstein <[email protected]> Fwd: Introducing Leidos Health Wed, 23 Apr 2014 19:17:12 +0000 HRMP_ Fact _Sheet.pdf; Virtual_Biotech Phanna_lnitiative.pd
Martin A. Date: Tue, Apr 22, 2014 at 10:45 AM Subject: Introducing Leidos Health To: "jeffrey*jeffreyspstein.org" <jeffrey_kjeffreyspstein.org> > Dear Jeffrey, I write to introduce myself and my organization. I used to work at the Juvenile Diabetes Research Foundation (JDRF) and most recently; I was a fo
rom: To: Subject: Date: Attachments: Jeffrey Epstein <[email protected]> Fwd: Introducing Leidos
son. I look forward to hearing from you. Thank you/Gracias, Martin Martin A. Duenas, MPA Director I Health Research Management Practice Managed Life Sciences cell (1): cell (2): I www.leidos.com/health EFTA00663598 This email and any attachments to it are intended only for the identified recipients.
To: Sana Alajmovic[ - From: Jeffrey Epstein Sent: Tue 12/4/2012 10:34:58 PM Subject: Re: Mr. G. Steven Burrill sorry i didn't get to meet you , that was the main dissappointment On Tuc, Dc
Mr. G. Steven Burrill sorry i didn't get to meet you , that was the main dissappointment On Tuc, Dcc 4, 2012 at 11:14 PM, Sana Alajmovic < wrote: Dear Jeffrey, We are sad that you could not join us last Saturday but I understand you have a busy schedule. I wanted to ask you whether I have your permission
Burrill & Company - a global venture capital firm within Life Sciences? I met him through SALSS and having on several occassions told him about the Jeffrey Epstein Foundation, he became very interested in your support of cutting edge research. Mr. Burrill himself was recognized as a biotech investment
To: Sana Alajmovic[ - From: Jeffrey Epstein Sent: Tue 12/4/2012 10:34:58 PM Subject: Re: M
whether I have your permission to introduce you to Mr. G. Steven Burrill, Founder & CEO of Burrill & Company - a global venture capital firm within Life Sciences? I met him through SALSS and having on several occassions told him about the Jeffrey Epstein Foundation, he became very interested in your support
From: Sent: Tuesday, December 4, 2012 9:19 PM To: Epstein Jeffrey Cc: Subject: Prescription from Life Sciences Your prescription from Life Sciences has arrived the house (this is what =r. Merrell called in for you).
: Sent: Tuesday, December 4, 2012 9:19 PM To: Epstein Jeffrey Cc: Subject: Prescription from Life Sc
Tuesday, December 4, 2012 9:19 PM To: Epstein Jeffrey Cc: Subject: Prescription from Life Sciences
From: Sent: Tuesday, December 4, 2012 9:19 PM To: Epstein Jeffrey Cc: Subject: Prescription from Life Sciences Your prescription from Life Sciences has arrived the house (this is what =r. Merrell called in for you). Lyn will put it on the 6th floor in =our o
From: "Jeffrey E." <[email protected]> To: Deepak Chopra Subjec
From: "Jeffrey E." <[email protected]> To: Deepak Chopra Su
ww.cbs.dk/staff/sbibc. Transdisciplinary framework: Editor in chief of Cybernetics & Human Knowing 2015 JPBMB Special Issue on Integral Biomathies: Life Sciences, Mathematics and Phenomenological Philosophy (note: free access to all articles until July 19th, 2016) EFTA00822674 Fra: [mailto: PA vegne of
o this sector, especially to the regional banks, even through near term volatility. GIO Investments Strategy EFTA00862331 Anton Pil Jeanne Sun Peter Epstein Source: Bloomberg. As of March 2015. IMPORTANT INFORMATION The opinions and views expressed herein are those of GICI and may differ from those oft
tegy EFTA00862331 Anton Pil Jeanne Sun Peter Epstein Source: Bloomberg. As of March 2015. IMPORTANT
ds. While we still like many of the companies longer term, the credit card networks and NFC chip makers may become more volatile in the near term. Life Sciences Last year we highlighted an opportunity in Life Sciences, particularly those focusing on genetic testing. While we still like some companies longe
From: Lesley Groff To: Jefffrey Epstein Subject: Fwd: To Professor White - P.S. Date: Fri, 05 May 2017 11:30:30 +0000 Sent from my iPhone Begin forwarded message: From: MARK TRAMO Date:
From: Lesley Groff To: Jefffrey Epstein Subject: Fwd: To Professor White - P.S. Date: Fr
e resonates with yours re: solidifying relationships through interdisciplinary teaching in Letters & Sciences that connects interrelated programs in Life Sciences, which you and she actualized this year for Neuroscience, Psychobiology, CogSci, and Music School students getting credit towards their majors and
[email protected] <mailto:[email protected]> " <[email protected] <mailto:[email protected]» Subject: Invitations for Symposium Dear Jeffrey, On behalf of Yuri Milner I am sending you invitations for two panel discussions about the future of Fundamental Physics and Life Sciences at Stanf
[email protected]» Subject: Invitations for Symposium Dear Jeffrey, On behalf of Yuri Milner I am sending you invit
ymposium Dear Jeffrey, On behalf of Yuri Milner I am sending you invitations for two panel discussions about the future of Fundamental Physics and Life Sciences at Stanford University and UCSF accordingly. Please do not hesitate to contact me if you have any questions. Best regards, Anna EFTA_R1_01972078
From: Misha Gromov Sent: Monday, October 2, 2017 3:14 PM To: jeffrey E. Subject: Fwd: Arnold J. Levine, Adventures in Cancer Immunotherapy: The Role of the Immune System in Cancer Therapy Original Message Subject: Ar
o: Having trouble viewing this email? Click here [1] [2] 131 ADVENTURES IN CANCER IMMUNOTHERAPY: THE ROLE OF THE IMMUNE SYSTEM IN CANCER THERAPY Life Sciences Speaker: Arnold J. Levine Wednesday, October 4, 2017 4:15PM Tea; 5:00PM Lecture Add to Calendar [4] [5] In the 1960s, Lewis Thomas postulated t
Entities connected to both Jeffrey Epstein and Life Sciences